New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.The companies, namely Sun Pharma, Zydus Lifesciences, and Dr. Reddy’s Laboratories, launched their variants a day after Hyderabad-based Natco Pharma launched its generic semaglutide injection in India, priced at Rs 1,290 per month.Sun Pharma launched semaglutide…
Trending
- Adarsh Baal Vidyalaya Review: A Heartwarming Triumph on India’s Education System
- Musafir Cafe Review: Vikrant Massey’s Soulful Netflix Drama Is A Ode To Old-School Love
- Jana Nayagan Movie Review: Vijay’s Grand Farewell Is a Blockbuster Spectacle Fans Will Never Forget
- Max, Min & Miyaowzaki Movie Review: A Heartwarming Tale of Love, Loss & Healing Across Three Generations
- Dastaar Movie Review: Tarsem Jassar’s Powerful Sikh Resilience Drama
- Diamond Made Man Part 2 Review: A Cosmic Sci-Fi Spectacle That Soars
- ‘Oka Court Case’ 2026 Movie Review: A Fresh Legal Love Drama That Wins Hearts
- Rahun Main Tere Rubaru Review: A Gripping Tale of Love, Danger & Deception